Cromatografia liquida ad alte prestazioni in fase inversa: un metodo robusto per la quantificazione di acidi sialici marcati in fluorescenza e derivatizzati isolati dal fegato di topo

Executive Industry Relevance

Quantitative analysis of sialic acids supports target validation in glycobiology and biomarker discovery. This RP-HPLC method enables precise measurement of Neu5Ac and Neu5Gc levels, providing mechanistic de-risking for therapeutic hypotheses involving sialic acid metabolism. The approach enhances predictive confidence in preclinical models by delivering reproducible, fluorescence-based quantitation.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of therapeutic hypotheses related to sialic acid biosynthesis pathways.
• Operational Value: Provides quantitative readouts for functional target validation in disease-relevant systems.
• Scientific Value: Supports predictive confidence through measurable changes in Neu5Gc levels upon genetic perturbation.

Screening & Assay Development

• Scientific Value: Generates stable, fluorescent derivatives suitable for standardized assay formats.
• Operational Value: Ensures reproducibility via consistent derivatization and chromatographic separation.
• Scientific Value: Delivers quantitative dependent variable measurements for compound screening campaigns.

Translational & Preclinical Research

• Scientific Value: Aligns with disease-relevant systems by quantifying sialic acids in mouse liver tissue.
• Operational Value: Facilitates continuity from discovery through preclinical validation with standardized outputs.
• Scientific Value: Supports risk-adjusted advancement decisions via biomarker-level quantification.

Pipeline & Workflow Integration

This method integrates into the discovery continuum from early target validation through preclinical screening by providing quantitative, fluorescence-based sialic acid measurements.

• Discovery Biology: Supports hypothesis testing and pathway clarification in sialic acid metabolism.
• Screening: Enables assay readiness through reproducible derivatization and chromatographic separation.
• Analytics: Provides quantitative fluorescence readouts at 373 nm excitation and 448 nm emission for comparative analysis.
• Translational Research: Connects to preclinical continuity via measurable sialic acid levels in biological samples.
• Enterprise Reuse: Establishes a reusable platform for sialic acid analysis across multiple tissue types and models.

Operational & Enterprise Impact

• Scientific Value: Predictive confidence in target validation through precise Neu5Ac/Neu5Gc quantification.
• Operational Value: Standardization and reproducibility via standardized derivatization and RP-HPLC conditions.
• Strategic Value: Better go/no-go decisions by reducing mechanistic ambiguity in glycobiology targets.
• Portfolio Impact: Risk-adjusted prioritization based on quantitative sialic acid biomarkers.

Implementation Considerations

• Requires expertise in carbohydrate chemistry and fluorescence detection.
• Needs RP-HPLC system with C-18 column and fluorescence detector.
• Demands standardization of derivatization protocols across teams.
• Involves adaptation considerations for different sialic acid sources.
• Limited by the need for optimized mobile phase conditions for hydrophobic interaction.

Biopharma FAQs